Table 2:
Area | Specific improvement | Population in need |
---|---|---|
Epidemiology | Inclusion of disadvantaged groups in clinical trials and other clinical studies. | Disadvantaged groups |
Endotypes | Simple definitions for endotyping accessible to all institutions. | All patients |
Prevention | Low-impact interventions to prevent AD in all risk groups, especially from infancy. | Primarily children |
Comorbidity | Improved understanding of the mechanisms of comorbidity development to facilitate mitigation. | All patients |